simendan has been researched along with Myocarditis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alici, H; Cakici, M; Davutoglu, V; Ercan, S; Kus, E; Sari, I | 1 |
| Elisha, N; Paret, G; Rubinsthein, M; Salem, I | 1 |
| Kumar, A; Kushwah, S; Sahana, KS | 1 |
| de Albernaz Muniz, RZ; de March Ronsoni, R; Feijó, RV; Filho, WJ; Melo, LH; Moro, A; Schwingel, FL; Weber, S | 1 |
| Baumert, JH; Hein, M; Roehl, AB; Rossaint, R; Scherer, K; Steendijk, P | 1 |
| Hoffmeister, HM; Oikonomopoulos, T; Szabo, S | 1 |
| Filippatos, G; Parissis, JT | 1 |
| Kytö, V; Latva-Hirvelä, J; Levijoki, J; Saraste, A; Saukko, P; Vuorinen, T | 1 |
| Kilo, J; Schermer, E; Schweigmann, U; Velik-Salchner, C | 1 |
| Busani, S; Girardis, M; Ligabue, G; Lugli, R; Malavasi, V; Pasetto, A | 1 |
| Braun, JP; Dohmen, P; Döpfmer, U; Schneider, M | 1 |
11 other study(ies) available for simendan and Myocarditis
| Article | Year |
|---|---|
Rapid recovery from acute myocarditis under levosimendan treatment: report of two cases.
Topics: Acute Disease; Adult; Cardiotonic Agents; Echocardiography; Humans; Hydrazones; Male; Middle Aged; Myocarditis; Pyridazines; Simendan | 2013 |
Enteroviral myocarditis requiring extracorporeal membranous oxygenation in a 2 week old girl.
Topics: Cardiopulmonary Resuscitation; Cardiotonic Agents; Echocardiography; Enterovirus B, Human; Enterovirus Infections; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Humans; Hydrazones; Infant, Newborn; Myocarditis; Pyridazines; Severity of Illness Index; Simendan; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
Levosimendan. A promising future drug for refractory cardiac failure in children?
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Electrocardiography; Female; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocarditis; Pyridazines; Simendan | 2016 |
The use of Levosimendan for myocardiopathy due to acute Chagas' disease.
Topics: Acute Disease; Cardiotonic Agents; Chagas Cardiomyopathy; Humans; Hydrazones; Myocarditis; Pyridazines; Simendan | 2009 |
Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Topics: Animals; Blood Gas Analysis; Cardiotonic Agents; Dobutamine; Female; Heart Ventricles; Hemodynamics; Hydrazones; Inflammation Mediators; Milrinone; Myocardial Infarction; Myocardial Ischemia; Myocarditis; Myocardium; Myoglobin; Neutrophil Infiltration; Pyridazines; Simendan; Swine; Troponin T | 2009 |
Myocarditis.
Topics: Antineoplastic Agents; Cardiotonic Agents; Humans; Hydrazones; Myocarditis; Pyridazines; Simendan | 2009 |
Levosimendan in viral myocarditis: not only an inodilator but also a cardioprotector?
Topics: Heart Failure; Humans; Hydrazones; Myocarditis; Oxidative Stress; Pyridazines; Simendan; Vasodilator Agents | 2009 |
Effects of levosimendan in experimental acute coxsackievirus myocarditis.
Topics: Animals; Cardiotonic Agents; Coxsackievirus Infections; Heart Failure; Hydrazones; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Pyridazines; Simendan; Ventricular Function, Left | 2009 |
How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure.
Topics: Adolescent; Cardiomyopathies; Cardiotonic Agents; Catecholamines; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Humans; Hydrazones; Infant; Male; Milrinone; Myocarditis; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Simendan | 2011 |
Levosimendan in a case of severe peri-myocarditis associated with influenza A/H1N1 virus.
Topics: Cardiotonic Agents; Humans; Hydrazones; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Myocarditis; Pyridazines; Severity of Illness Index; Simendan; Treatment Outcome | 2012 |
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support.
Topics: Anti-Bacterial Agents; Antifungal Agents; Calcium; Candidiasis; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Cross Infection; Echocardiography; Female; Fluconazole; Heart Ventricles; Heart-Assist Devices; Humans; Hydrazones; Immunoglobulins; Intubation, Intratracheal; Myocarditis; Pyridazines; Simendan; Time Factors; Treatment Outcome; Ventricular Function, Left | 2004 |